ArticleBMJ case reports2022

Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy.

Zachary Holmes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.